| Detected | Trial | Change |
|---|---|---|
| 2026-05-29 | NCT04305054 Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational… |
Trial completed |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-04 | NCT07626398 All-Trans Retinoic Acid for the Treatment of Hemophagocytic Lymphohistiocytosis | Phase 2/3 | Not Yet Recruiting |
| 2026-05-19 | NCT07597395 ATRA for Management of Primary ITP | Phase 3 | Not Yet Recruiting |
| 2026-05-14 | NCT07586813 Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia… | Phase 2 | Recruiting |
| 2026-05-14 | NCT07586826 Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia… | Phase 2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07503730 | Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid… | APL | Recruiting |
| NCT06706401 | Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma | Oropharynx Cancer | Recruiting |
| NCT07296445 | A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic… | Acute Promyelocytic Leukemia (APL) | Not Yet Recruiting |
| NCT02339740 | Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic… | Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA | Active, Not Recruiting |
| NCT07597395 | ATRA for Management of Primary ITP | Immune Thrombocytopenia | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT07626398 | All-Trans Retinoic Acid for the Treatment of Hemophagocytic Lymphohistiocytosis | Hemophagocytic Lymphohistiocytosis (HLH) | Not Yet Recruiting |
| Phase 2 | |||
| NCT06484920 | A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of… | Relapsed Hodgkin Lymphoma | Recruiting |
| NCT05345002 | All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma | Glioma | Recruiting |
| NCT07586813 | Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia… | Persistent Isolated Chemotherapy-Induced Thrombocytopenia | Recruiting |
| NCT07586826 | Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia… | Persistent Isolated Chemotherapy-Induced Thrombocytopenia | Recruiting |
| NCT01409161 | Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients… | Acute Promyelocytic Leukemia With PML-RARA | Recruiting |
| NCT04241276 | A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer | Pancreatic Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT07348107 | ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With… | Advanced Pancreatic Ductal Adenocarcinoma | Not Yet Recruiting |
| NCT04919369 | All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or… | Metastatic Lung Non-Small Cell Carcinoma | Active, Not Recruiting |